These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8390368)
21. Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides. Youssefyeh RD; Campbell HF; Klein S; Airey JE; Darkes P; Powers M; Schnapper M; Neuenschwander K; Fitzpatrick LR; Pendley CE J Med Chem; 1992 Mar; 35(5):895-903. PubMed ID: 1312602 [TBL] [Abstract][Full Text] [Related]
22. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice. Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508 [TBL] [Abstract][Full Text] [Related]
23. 5-HT3 receptor-independent inhibition of the depolarization-induced 86Rb efflux from human neuroblastoma cells, TE671, by ondansetron. Toral J; Hu W; Critchett D; Solomon AJ; Barrett JE; Sokol PT; Ziai MR J Pharm Pharmacol; 1995 Jul; 47(7):618-22. PubMed ID: 8568632 [TBL] [Abstract][Full Text] [Related]
24. Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats. Beardsley PM; Lopez OT; Gullikson G; Flynn D Alcohol; 1994; 11(5):389-95. PubMed ID: 7818797 [TBL] [Abstract][Full Text] [Related]
25. Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon. Kadowaki M; Wade PR; Gershon MD Am J Physiol; 1996 Nov; 271(5 Pt 1):G849-57. PubMed ID: 8944700 [TBL] [Abstract][Full Text] [Related]
26. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness. Levine ME; Chillas JC; Stern RM; Knox GW Aviat Space Environ Med; 2000 Nov; 71(11):1111-4. PubMed ID: 11086664 [TBL] [Abstract][Full Text] [Related]
27. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist. Yoshikawa T; Yoshida N; Oka M Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861 [TBL] [Abstract][Full Text] [Related]
28. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. Kuryshev YA; Brown AM; Wang L; Benedict CR; Rampe D J Pharmacol Exp Ther; 2000 Nov; 295(2):614-20. PubMed ID: 11046096 [TBL] [Abstract][Full Text] [Related]
29. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron. Castejon AM; Paez X; Hernandez L; Cubeddu LX J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811 [TBL] [Abstract][Full Text] [Related]
30. Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Villalón CM; den Boer MO; Heiligers JP; Saxena PR Br J Pharmacol; 1991 Jan; 102(1):107-12. PubMed ID: 2043916 [TBL] [Abstract][Full Text] [Related]
31. Effect of neostigmine on metoclopramide-induced aldosterone secretion in man. Sommers DK; Meyer EC; van Wyk M Eur J Clin Pharmacol; 1989; 36(4):411-3. PubMed ID: 2737235 [TBL] [Abstract][Full Text] [Related]
32. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron. Barnes JM; Barnes NM Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263 [TBL] [Abstract][Full Text] [Related]
33. Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation. Martin C; Roman V; Agay D; Fatôme M Radiat Res; 1998 Jun; 149(6):631-6. PubMed ID: 9611102 [TBL] [Abstract][Full Text] [Related]
34. Block of the delayed rectifier current (IK) by the 5-HT3 antagonists ondansetron and granisetron in feline ventricular myocytes. de Lorenzi FG; Bridal TR; Spinelli W Br J Pharmacol; 1994 Oct; 113(2):527-35. PubMed ID: 7834204 [TBL] [Abstract][Full Text] [Related]
35. A component of 5-HT-evoked depolarization of the rat isolated vagus nerve is mediated by a putative 5-HT4 receptor. Rhodes KF; Coleman J; Lattimer N Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):496-503. PubMed ID: 1470221 [TBL] [Abstract][Full Text] [Related]
36. The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist. Upward JW; Arnold BD; Link C; Pierce DM; Allen A; Tasker TC Eur J Cancer; 1990; 26 Suppl 1():S12-5. PubMed ID: 2169778 [TBL] [Abstract][Full Text] [Related]
37. Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers. Grady TA; Broocks A; Canter SK; Pigott TA; Dubbert B; Hill JL; Murphy DL Psychiatry Res; 1996 Aug; 64(1):1-10. PubMed ID: 8888359 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the effectiveness of metoclopramide, ondansetron, and granisetron on the prevention of nausea and vomiting after laparoscopic cholecystectomy. Oksuz H; Zencirci B; Ezberci M J Laparoendosc Adv Surg Tech A; 2007 Dec; 17(6):803-8. PubMed ID: 18158814 [TBL] [Abstract][Full Text] [Related]
39. The effect of neostigmine on metoclopramide-induced aldosterone secretion after the administration of muscarinic antagonists in man. Sommers DK; Meyer EC; van Wyk M Eur J Clin Pharmacol; 1990; 38(4):401-3. PubMed ID: 2344865 [TBL] [Abstract][Full Text] [Related]
40. Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting. Plosker GL; Benfield P Pharmacoeconomics; 1996 Apr; 9(4):357-74. PubMed ID: 10160110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]